BioSim Innovations, a contract research and development organization that connects engineering principles to clinically relevant experiences for device and therapy evaluation, has closed a $22.3M Series b funding round. The capital infusion marks a significant step for the firm, which embraces the challenge of designing and delivering efficient, synergistic, and strategic studies.
This fresh investment will enable BioSim Innovations to further its specialized R&D support, helping clients navigate the complex landscape of medical device and therapy development. The funding underscores the growing demand for its expertise in creating robust evaluation frameworks.
